IPO

IPO Synopsis

Speciality Medicines Ltd
Registered Office: 913 One World West S.No.396 FP,Village-Vejalpur , Ahmedabad - 380051 , Gujarat , India.
Phone : +91 22 4604 5344   Fax:
Email :  investors.grievances@specialitymedicaine.com  
Website :  www.specialitymedicine.com
Initial public issue of up to 23,50,000 equity shares of face value of Rs10/- each of Speciality Medicines Limited ("SML" or the "Company" or the "Issuer") for cash at a price of Rs124 per equity share including a share premium of Rs114 per equity share (the "Issue Price") aggregating to Rs29.14 Crores ("the Issue"), of which up to 1,50,000 equity shares of face value of Rs10/- each for cash at a price of Rs124 per equity share including a share premium of Rs114 per equity share aggregating to Rs1.86 Crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. Net issue of 22,00,000 to be updated equity shares of face value of Rs10/- each at a price of Rs124 per equity share including a share premium of Rs114 per equity share aggregating to Rs27.28 Crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.75% and 25.04%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs10/- each. Price Band: Rs124 per equity share of face value of Rs10 each. The floor price is 12.40 times of the face value. Bids can be made for a minimum of 2000 equity shares and in multiples of 1000 equity shares thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
20-Mar-26 24-Mar-26 Rs 124.00-0.00 Rs 0.00-0.00
Minimum Application for shares in Nos :2000  Further Multiples of :1000
  (Rs Cr) Lead Managers to the Issue
Project Cost 25.58
Unistone Capital Private Limited
Project Financed through Current Offer 29.14
Post Issue Equity Share Capital 8.79
Issue Price Rs 124.00
Projects
Setting up of Research & Development (R&D) Center To meet working capital requirements
Product Registration in International Markets and Product Development for sale in international markets General corporate purposes
Funding for Marketing and Promotional Activities
Promoted By Listing At Registrar to the Issue
  Parth Goyani
  Sumit Goyani
 BSE - SME
No Data Found.
Monday, March 30, 2026
Adani Ports1313.40(-1.81)%
      
Asian Paints2164.50(-1.94)%
      
Axis Bank1161.95(-3.59)%
      
Bajaj Finance801.40(-5.09)%
      
Bajaj Finserv1631.60(-3.71)%
      
Bharat Electro..400.60(-1.03)%
      
Bharti Airtel1784.30(-3.14)%
      
Eternal229.05(-1.74)%
      
HCL Technologi..1341.15(-1.65)%
      
HDFC Bank731.80(-3.23)%
      
Hind. Unilever2055.80(-0.93)%
      
ICICI Bank1205.20(-2.35)%
      
Infosys1251.20(-1.48)%
      
Interglobe Avi..3943.75(-3.80)%
      
ITC287.70(-2.39)%
      
Kotak Mah. Ban..353.20(-3.48)%
      
Larsen & Toubr..3504.30(-1.73)%
      
M & M2956.15(-2.79)%
      
Maruti Suzuki12298.80(-0.72)%
      
NTPC370.95(-1.32)%
      
Power Grid Cor..296.20(0.27)%
      
Reliance Indus..1344.25(-0.30)%
      
SBI979.80(-3.95)%
      
Sun Pharma.Ind..1757.35(-2.13)%
      
Tata Steel191.80(-0.75)%
      
TCS2359.05(-1.29)%
      
Tech Mahindra1386.70(-0.31)%
      
Titan Company3952.10(-0.74)%
      
Trent3294.65(-3.10)%
      
UltraTech Cem.10744.95(-2.78)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)